iNTRoducTioN
The age of a cow affects several economically important production traits in beef cattle, including milk yield and calf weaning weight. For example, increased milk yield and weaning weights were shown to be positively correlated with age in 3 to 6 yr old Angus cows (Baker and Boyd, 2003) . Conversely, cows ≥ 8 yr of ABSTRAcT: Aged beef cows (≥ 8 yr of age) produce calves with lower birth and weaning weights. In mammals, aging is associated with reduced hepatic expression of glutamine synthetase (GS) and alanine transaminase (ALT), thus impaired hepatic Gln-Glu cycle function. To determine if the relative protein content of GS, ALT, aspartate transaminase (AST), glutamate transporters (EAAC1, GLT-1), and their regulating protein (GTRAP3-18) differed in biopsied liver tissue of (a) aged vs. young (3 to 4 yr old) nonlactating, nongestating Angus cows (Exp. 1 and 2) and (b) aged mixed-breed cows with and without COMPU-DOSE (17β-estradiol) ear implants (Exp. 3), Western blot analyses were performed. In Exp. 1, 12 young (3.62 ± 0.01 yr) and 13 aged (10.08 ± 0.42 yr) cows grazed the same mixed forage for 42 d (August-October). In Exp. 2, 12 young (3.36 ± 0.01 yr) and 12 aged (10.38 ± 0.47 yr) cows were individually fed (1.03% of BW) a corn-silage-based diet to maintain BW for 20 d. For both Exp. 1 and 2, the effect of cow age was assessed by ANOVA using the MIXED procedure of SAS. Cow BW did not change (P ≥ 0.17). Hepatic ALT (78% and 61%) and GS (52% and 71%) protein content (Exp. 1 and 2, respectively) was decreased (P ≤ 0.01), whereas GTRAP3-18 (an inhibitor of EAAC1 activity) increased (P ≤ 0.01; 170% and 136%) and AST, GLT-1, and EAAC1 contents did not differ (P ≥ 0.17) in aged vs. young cows. In Exp. 2, free concentrations (nmol/g) of Glu, Ala, Gln, Arg, and Orn in liver homogenates were determined. Aged cows tended to have less (P = 0.10) free Gln (15.0%) than young cows, whereas other AA concentrations did not differ (P ≥ 0.26). In Exp. 3, 14 aged (> 10 yr) cows were randomly allotted (n = 7) to sham or COMPUDOSE (25.7 mg of 17β-estradiol) implant treatment (TRT), and had ad libitum access to alfalfa hay for 28 d. Blood and liver biopsies were collected 14 and 28 d after implant treatment. Treatment, time after implant (DAY), and TRT × DAY effects were assessed by ANOVA using the MIXED procedure of SAS. Cow BW was not affected (P ≥ 0.96). Implant increased (P ≤ 0.02) total plasma estradiol by 220% (5.07 vs. 1.58 pg/mL) and GS protein by 300%, whereas the relative content of other proteins was not altered (P ≥ 0.16). We conclude that hepatic expression of ALT and GS are reduced in aged vs. young cows, and administration of 17β-estradiol to aged cows increases plasma estradiol and hepatic GS, but not that of other proteins that support hepatic Glu metabolism. age produce calves with lower birth and weaning weights (BIF, 1996) and daughters with reduced milk yield and productive lifespans (Fuerst-Waltl et al., 2004) .
The physiological mechanisms responsible for these aging related effects are not understood. However, aging of mammals is associated with decreased hepatic expression and function of proteins responsible for intermediary metabolism (Schmucker, 2005; Serste and Bourgeois, 2006) , including decreased activity of glutamine synthetase (GS) in mice (Dhahbi et al., 1999) and alanine transaminase (ALT) in rats (Harding et al., 1961) . These findings suggest that hepatic expression of GS, ALT, aspartate transaminase (AST), and highaffinity glutamate transport proteins (eAAc1, GLT-1) may be compromised in aged cows (Stoll et al., 1991; Welbourne et al., 2001; Cadoret et al., 2002) .
Preliminary findings (Sipe, 2004 ) from a growth study with finishing steers indicated that a SYNOVEX-S (20 mg 17β-estradiol benzoate + 200 mg progesterone) ear implant increases hepatic GS mRNA and protein content. Consistently, 17β-estradiol administration increased GS mRNA and protein in human brain tissue (Blutstein et al., 2006) and GS protein content and activity in rat C6-glioma cells (Haghighat, 2005) . In contrast to its effects on GS, 17β-estradiol administration decreased ALT and AST content in the brain and liver of rats (Moorthy et al., 2005) . Therefore, the objectives of this project were to determine if expression of GS, ALT, AST, and glutamate transporter-associated proteins differed (a) in aged vs. young beef cows and (b) in 17β-estradiol implanted vs. nonimplanted aged beef cows.
mATeRiALS ANd meTHodS

Animals
All experimental animal procedures were approved by the University of Kentucky Institutional Animal Care and Use Committee. Experiment 1. Twenty-five nonpregnant, nonlactating Angus beef cows grazed the same mixed forage pasture (12.1 ha; nonendophyte infected fescue, bluegrass, and orchardgrass) for 42 d (August-October). All cows had ad libitum access to a conventional freechoice beef cow vitamin-mineral supplement (UK Gestating Beef Mineral; Burkmann Feeds, Danville, KY) and fresh water. The treatments were young (n = 12; age = 3.62 ± 0.01 yr; BW = 582 ± 35.3 kg) vs. aged (n = 12; age = 10.08 ± 0.42 yr; BW = 683 ± 21.1 kg) cows.
Experiment 2. Twenty-four nonpregnant, nonlactating predominately Angus beef cows were fed in individual pens a standard corn-silage diet (10% CP on DM basis, 1.50 Mcal/kg) at 1.03% of BW to meet their maintenance requirements for 20 d (April 6-26). Diet contained a conventional beef cow vitamin-mineral mix (UK Gestating Beef Mineral). Soybean meal was added to supplement corn silage and formulate a 9.5% CP diet. All cows had ad libitum access to fresh water. The treatments were young (n = 12; age = 3.36 ± 0.01 yr; BW = 549 ± 13.5 kg) vs. aged (n = 12; age = 10.38 ± 0.47 yr; BW = 688 ± 15.1 kg) cows.
Experiment 3. Fourteen aged (> 10 yr; as determined by the amount of wear on their teeth; Johnson, 1959) nonpregnant beef cows were obtained from a stockyard and housed in a dry lot. After adaptation to an alfalfa hay diet (21 d), cows were weighed and subdivided into 2 groups based on BW and then randomly allotted (n = 7) to either receive a sham (control; 0.5 mg oxytetracycline; BW = 585 ± 28.2 kg) or estradiol (COMPUDOSE Implant; 25.7 mg 17β-estradiol; 0.5 mg oxytetracycline; Vetlife, Des Moines, IA; BW = 621 ± 30.0 kg) implant treatment. The back of the ear was clipped, cleansed with 70% ethyl alcohol solution, and dried. Seven cows received the controlled-release estrogen implant subcutaneously in the dorsal-medial area of the left ear using the manufacturer's implantation device (COMPUDOSE Implanter; Vetlife) and instructions. In addition, the 7 control cows received a sham implant (consisting of 1 mL of sterile corn oil as a vehicle for the oxytetracycline) in the back of an ear. Cows had ad libitum access to alfalfa hay, a conventional free-choice beef cow vitamin-mineral supplement (UK Gestating Beef Mineral) and water for 28 d.
Diet Sampling and Analysis
Experiment 1. Leaf-blade samples suitable for grazing were detached from the pasture on d 21 of the 42 d trial. Samples were taken systematically from approximately 30 sites using a knife to cut the forage at approximately 2 cm above soil, immediately placed into individual plastic bags and placed on ice, frozen, 
Analysis of Plasma Estradiol and Progesterone
Jugular venous blood samples were collected by venipuncture on d 14 and d 28 of Exp. 3. For preparation of plasma, 16 mL of blood was collected in EDTA-containing (0.9375 mg/mL) blood collection tubes (Becton Dickinson, Franklin Lakes, NJ), plasma recovered by refrigerated centrifugation at 3,000 × g for 10 min at 4°C, and then stored at −80°C.
Plasma estradiol levels (pg/mL) were evaluated using the Ultra-Sensitive Estradiol Radioimmunoassay kit (Diagnostic Systems Labs, Webster, TX). Briefly, 125 μL of MgCl 2 and 125 μL Dextran were added to microcentrifuge tubes containing 750 μL of the samples to dilapidate the plasma. Samples were incubated for 1 h at room temperature. Tubes were centrifuged for 15 min at 10,000 rpm and the supernatant removed for analysis. Using the RIA kit, all samples, standards, and controls were assayed in duplicate. Tubes provided from the kit were labeled for total counts, nonspecific binding, standards, controls, and blood samples. The standards used were 0.5, 0.62, 1, 2. 5, 5, 7.5, 10, 15, 20, 35, 50 , and 250 pg/mL. The volume for the standards and controls was 200 μL per tube, and 266.7 μL of plasma samples were added to the proper tubes. To the nonspecific binding tubes, 300 μL of the 0 pg/mL estradiol standard was added. Estradiol antiserum (first antibody; 100 μL) was added to all tubes except for the nonspecific binding tubes and total count tubes. All tubes were vortexed and allowed to incubate overnight at 4°C. After the incubation, 125 iodine-labeled estradiol (100 μL) was added to each tube. Then, tubes were vortexed, covered, and allowed to incubate at 4°C overnight. On the third day, precipitating reagent (secondary antibody; 1 mL) was added to all tubes except for total count tubes. Tubes were incubated at room temperature for 1 h. Next, tubes were centrifuged for 30 min at 4°C and 3,000 rpm. The tubes were decanted except for the total count tube to remove any excess liquid moisture. Afterward, tubes were counted in the γ counter for 1 min. The intraassay CV was 7.1%, whereas the interassay CV was 11.9%. The detection limit of this assay is 0.67 pg/mL. Plasma progesterone levels (ng/mL) were measured using the Coat-A-Count Progesterone 125 I Radioimmunoassay kit per manufacturer's instructions (Siemens Medical Solutions Diagnostics, Los Angeles, CA). The sensitivity of this assay was determined to be 0.038 ng/mL, with an intraassay CV of 5% and an interassay CV of 11%.
Liver Tissue Biopsy
Hepatic tissue samples (typically 1.2 to 1.8 g) were collected after 42 d of grazing pasture (Exp. 1), 20 d of consuming a common corn silage diet (Exp. 2), and 14 and 28 d after hormone treatment (Exp. 3), using a modification (Brown et al., 2009 ) of the aspiration technique in cattle (Boling and Nuzum, 1975) . The tissue was either processed immediately for AA analysis (200 mg) or placed in foil packs and snap-frozen in liquid nitrogen and storage at −80°C until use for Western blot analysis (200 mg) or held as a reserve (balance).
AA Analysis
Tissue was homogenized (setting 11, POLY-TRON, Model PT10/35; Kinematic, Inc., Neuchâtel, Switzerland) in 10 volumes of ice-cold 10% (wt/vol) perchloric acid to precipitate proteins. Supernatants were isolated by centrifugation at 1,500 × g for 15 min at 4°C, neutralized with potassium hydroxide, and stored at −80°C until analyzed for AA content. Liverfree AA were determined after o-phthaldialdehyde derivization, HPLC separation, and fluorometric detection (Wu and Knabe, 1994) . The AA values were generated as supernatant µM and are reported as nmol AA/g extracted liver tissue.
Immunoblot Analysis
For all experiments, immunoblot and densitometric analyses for the relative expression of targeted proteins were performed as described by Brown et al. (2009) , except that 200 mg of biopsied liver tissue was used instead of the 1 g collected at slaughter. Specifically, liver tissue was homogenized on ice for 30 s (setting 11, POLYTRON) in 7.5 mL of 4°C sample extraction buffer solution (0.25 mM sucrose, 10 mM HEPES-KOH pH 7.5, 1 mM EDTA, and 50 μL of protease inhibitor; Sigma, St. Louis, MO). Protein was quantified by a modified Lowry assay, using bovine serum albumin as a standard (Kilberg, 1989) . Proteins were separated using 12% SDS-PAGE and electrotransferred to a 0.45-µm nitrocellulose membrane (BioRad, Hercules, CA) as previously described (Howell et al., 2001 (Howell et al., , 2003 , except that proteins were separated using a 12% acrylamide gel instead of 7.5%. Blots were stained with Fast-Green (Fisher Scientific, Pittsburg, PA) and the relative amount of stained protein per lane/sample determined by densitometric analysis.
The relative tissue content of specific proteins was evaluated using a standard immunoblot protocol as previously described (Howell et al., 2001 (Howell et al., , 2003 . For the detection of GLT-1, EAAC1, and GTRAP3-18, blots were hybridized with 5 to 10 µg of IgG antirat GLT-1 polyclonal antibody (Affinity BioReagents, Golden, CO), 1 µg of IgG antihuman EAAC1 polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and 4 µg of IgG antihuman GTRAP3-18 (Abcam Inc., Cambridge, MA), respectively, per mL of blocking solution (1% nonfat dry milk [wt/vol] All protein-primary antibody binding reactions were visualized with a chemiluminescence kit (Pierce, Rockford, IL) after hybridization of primary antibodies with horseradish peroxidase-conjugated donkey antirabbit IgG (Amersham, Arlington Heights, IL; GLT-1 and EAAC1, 1:5,000); horseradish peroxidaseconjugated goat antimouse IgG (BD Biosciences, San Jose, CA; GS, 1:5,000); horseradish peroxidase-conjugated rabbit antisheep IgG (Santa Cruz Biotechnology, Santa Cruz, CA; ALT and AST, 1:5,000); or horseradish peroxidase-conjugated donkey antigoat IgG (Santa Cruz Biotechnology; GTRAP3-18, 1:5,000).
Densitometric analysis of immunoreactive products was performed as described previously (Howell et al., 2003; Fan et al., 2004 , Xue et al., 2009 , 2011 . Briefly, after exposure of autoradiographic film (Amersham), digital images of all observed immunoreactive species were recorded and quantified (Yamin et al., 1996; Dehnes et al., 1998; Ding et al., 1998) Data were collected as arbitrary densitometric units and then were corrected for unequal loading and/or transfer of proteins by normalization to densitometric values of Fast-Green-stained proteins common to all immunoblot lanes/samples. Across all experiments, the range of Fast-Green normalization was ALT, 4.9% to 6.5%; AST, 7.2% to 9.5%; GS, 6.9% to 8.2%; GLT-1, 8.0% to 10.1%; GTRAP3-18, 6.5% to 8.7%; and EAAC1, 8.5% to 10.2%. For Exp. 1 and 2, densitometric values were normalized to young cows by obtaining an average young cow densitometric value and dividing all results by this value. For Exp. 3, densitometric values were normalized to the average d 14 control value for each protein by dividing the actual value for the animal by the average control value.
Statistical Analysis
All data comparisons are presented as the least squares means (± SEM), and cow was the experimental unit.
Experiments 1 and 2. Within young-and aged-cow treatment groups, beginning and final BW were compared by ANOVA (SAS, version 8.01, 2000; SAS Inst. Inc., Cary, NC). The effect of age on all experimental observations was evaluated using the MIXED procedure of SAS (SAS Inst. Inc.). Cow ages were Exp. 1, young 3.55-3.69 yr, aged 7.55-11.56 yr; Exp. 2, young 3.15-4.19 yr, aged 8.21-12.21 yr. The statistical model for each experimental observation included age as the fixed effect, with age and cow treated as class variables and cow (age) included in the random statement.
Experiment 3. Experimental parameters were evaluated for treatment differences by ANOVA (SAS Inst. Inc.), using the MIXED procedure of SAS and the REPEATED statement. The effects of estrogen treatment (TRT), time after implant (dAy), and their interaction (TRT × dAy) were assessed as fixed effects. Class variables were estrogen treatment (TRT), cow, and day, with cow (TRT) included in the random statement and subject for the REPEATED statement. Kenward-Roger adjustment was used to calculate the denominator df (Kenward and Roger, 1997) , and a first-order autoregressive covariance was used.
ReSuLTS
Experiment 1
The mean CP, crude fat, crude fiber, and ash values for the mixed grass pasture of Exp. 1 are presented in Table 1 . After 42 d of common grazing of this pasture, BW did not change (P ≥ 0.79) for either young (585 ± 14.9 vs. 582 ± 16.0 kg) or aged (683 ± 21.1 vs. 677 ± 22.2 kg) cows.
Immunoblot analysis was performed on proteins isolated from liver homogenates to test the hypothesis that the relative content of selected enzymes and transporters associated with hepatic Glu metabolism would differ in aged vs. young cows. In addition, because of its known role in amino acid carbon-derived gluconeogenesis (Brown et al., 2009) , the effect of aging on AST expression also was assessed. A single immunoreactive species for AST (39.3 to 42.6 kDa), ALT (22.6 to 23.0 kDa), GS (42.5 kDa), GLT-1 (72.8 to 75.8 kDa), EAAC1 (67.5 to 70.3 kDa), and GTRAP3-18 (40.4 to 41.2 kDa) was detected in liver homogenates of aged and young cows (Fig. 1) . Densitometric analyses (Table 2) found that the amount of AST, GLT-1, and EAAC1 did not differ (P ≥ 0.61) between aged and young cows. In contrast, the liver tissue of aged cows contained 78% (P = 0.01) and 38% (P = 0.01) less ALT and GS protein, respectively, than of young cows. However, the liver of aged cows contained 170% more (P = 0.02) GTRAP3-18 than did liver tissue isolated from the young cows.
Experiment 2
Because old cows consuming forages (pasture or hay) are often thought to consume less DMI due to loss of teeth (incisors) and reduced feed intake can affect BW and hepatic metabolism, a potential confounding factor of Exp. 1 findings was that feed intake by aged vs. young grazing cows was not measured. Thus, the effect of age on enzymes and transporters associated with the Gln-Glu cycle in hepatocytes could have potentially been confounded with differences in feed intake relative to BW. To obviate these potentially confounding factors, a controlled-intake study feeding a corn-silage-based diet (DM basis: 9.39% CP, 2.75% crude fat, 21.78% crude fiber, 3.74% ash, 57.6% TDN; Table 1 ) on a metabolic basis (1.50 Mcal/kg at 100% maintenance requirements and 1.03% of BW) was conducted to access the effect of age on the same parameters. The hypothesis tested was that hepatic content of aged cows would contain less ALT and GS, and more GTRAP3-18, protein than young cows, whereas EAAC1 and GLT-1 contents would not be affected.
After 20 d of consumption of a controlled amount of corn-silage diet, BW of young (581 ± 12.8 kg) and aged (724 ± 15.8 kg) cows did not change (P ≥ 0.85) compared with BW from d 0 (549 ± 13.5, 688 ± 15.1 kg, respectively). As found for Exp. 1, a single immunoreactive species (of essentially the same M r as found in Exp. 1) was detected for AST, ALT, GS, GLT-1, EAAC1, and GTRAP3-18 in liver homogenates of aged and young cows (data not shown). Closely paralleling the immunoblot findings from cows grazing a mixed-grass pasture, the liver tissue content of ALT and GS was decreased by 61% (P < 0.01) and 71% (P < 0.01), and content of GLT-1 (P < 0.18) and EAAC1 (P < 0.17) did not differ, whereas GTRAP3-18 content was increased (P < 0.05) 136% in aged vs. young cows fed corn silage figure 1. Immunoblot analysis of alanine transaminase (ALT), aspartate transaminase (AST), high affinity glutamate transporter-1 (GLT-1), excitatory amino acid carrier 1 (EAAC1), glutamine synthetase (GS), and glutamate transport associated protein 3-18 (GTRAP3-18) in homogenates (60 µg/Lane) of liver tissue biopsied from young vs. aged Angus cows grazing a mixed-grass pasture for 42 d (Exp. 1). Data are representative of n = 12 for young (age = 3.62 ± .01 yr) and n = 12 for aged (age = 10.08 ± 0.42 yr) cows. Apparent migration weights (kDa) for proteins were: ALT, 22.6 to 23.0; AST, 39.3 to 42.6; GS, 42.5 to 42.5; GLT-1, 72.8 to 75.8; EAAC1, 67.5 to 70.3; GTRAP3-18, 40.4 to 41.2. Across all experiments, the range of Fast-Green normalization was ALT, 4.9% to 6.5%; AST, 7.2% to 9.5%; GS, 6.9% to 8.2%; GLT-1, 8.0% to 10.1%; GTRAP3-18, 6.5% to 8.7%; and EAAC1, 8.5% to 10.2%. 1 Values (normalized arbitrary units) are arithmetic means and pooled least squares means (± SEM) of relative protein content from young (n = 12, age = 3.62 ± 0.01 yr) or aged (n = 12, age = 10.08 ± 0.42 yr) cows grazing a mixed forage pasture for 42 d before sampling.
2 Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; GS, glutamate synthetase; GLT-1, high affinity glutamate transporter-1; EAAC1, excitatory amino acid carrier 1; GTRAP3-18, glutamate transport associated protein 3-18. Values were normalized to the average Young value for each protein.
3 Most conservative error of the means.
for 20 d at a constant metabolic intake (Table 3) . To gain insight into the functional significance of reduced GS and ALT protein content in the liver homogenates of aged cows, free concentrations (nmol/g) of Glu, Ala, Gln, Arg, and Orn were determined (Table 4) . Aged cows tended to have less (P = 0.10) free Gln (15.0%) than young cows, whereas Glu, Ala, Arg, and Orn concentrations did not differ (P ≥ 0.48).
Experiment 3
The primary goal of Exp. 3 was to determine if administration of exogenous estradiol to aged beef cows, in the form of COMPUDOSE ear implants, affected the expression of GS, ALT, AST, and Glu transporter proteins involved in the hepatic Gln-Glu metabolism. The hypotheses tested were that supplemental exogenous estradiol would (1) increase plasma estradiol and (2) hepatic GS expression would be upregulated, ALT and AST protein expression would be downregulated, whereas EAAC1, GLT-1, and GTRAP3-18 would not be affected by exogenous estradiol supplementation.
To validate that estradiol implantation actually increased plasma estradiol levels, plasma estrogen levels were compared between control and implanted cows (Table 5 ). Estradiol levels of control cows were typical for cows during the luteal phase of the estrous cycle, whereas estradiol levels of implanted cows reflected those typical of the follicular phase (Ahmad et al., 1997) . The mean plasma estradiol concentrations of implanted cows were 151% (4.14 vs. 1.65 pg/mL) and 299% (5.99 vs. 1.50 pg/mL) greater (P = 0.01) than for control cows at d 14 and 28, respectively. In contrast, neither DAY nor TRT × DAY interactions were detected. These results reflect similarly increased levels of estrogen in estradiol-implanted cows at d 14 and 28 d after implantation, vs. nonimplanted control cows.
In contrast to estradiol, plasma progesterone levels were not affected (Table 5 ) by estradiol TRT (P = 0.23), DAY (P = 0.23), or TRT × DAY (P = 0.34). These results indicate that the administration of exogenous estradiol at this level did not affect plasma progesterone concentrations after 14 or 28 d of implantation. Thus, exogenous estradiol did not appear to affect the estrous cycle of implanted cows even though, quantitatively, the mean progesterone concentration of implanted cows was about 50% that of implanted cows on d 14 and nonimplanted cows on both d 14 and 28. Comparison of d 14 and d 28 estradiol and 1 Values (normalized arbitrary units) are arithmetic means and pooled least squares means ( ± SEM) of liver tissue homogenate AA concentrations from young (n = 12; average age = 3.36 ± 0.47 yr) vs. aged (n = 12, age = 10.38 ± 0.47 yr) cows.
2 Free AA in liver homogenates. 1 Values (normalized arbitrary units) are arithmetic means and pooled least squares means (± SEM) of relative protein content from young (n = 12, age = 3.36 ± 0.11 yr) or aged (n = 12, age = 10.38 ± 0.47 yr) cows consuming corn silage for 20 d.
3 Most conservative error of the means. progesterone levels within each cow (data not shown) revealed that all cows went through the estrous cycle during the experimental period. Cow BW were measured at d 0 (control, 585 ± 28.2 kg; implant, 621 ± 30.0 kg) and 28 (control, 577 ± 11.2 kg; implant, 613 ± 329.3 kg). No (P ≥ 0.96) TRT, DAY, or TRT × DAY effects on BW were found. These results indicate that despite an elevated blood estradiol, BW was not affected after 28 d of cows consuming alfalfa hay ad libitum.
Immunoblot analysis was performed to quantify the effect of estradiol-vs. sham-implants on liver expression of GS, ALT, AST, GLT-1, EAAC1, and GTRAP3-18 (Table 6 ). For GS, estradiol TRT (P = 0.01), DAY (P = 0.02), and TRT × DAY (P = 0.02) effects were found. More specifically, GS content was increased by 350% on d 14 and by 199% on d 28 in implanted vs. control cows. However, in contrast to GS, estradiol TRT did not affect (P ≥ 0.16) the relative content of any other evaluated protein. Although a DAY effect was observed for ALT (P = 0.03), AST (P = 0.08), GLT-1 (P = 0.01), EAAC1 (P = 0.08), and GTRAP3-18 (P = 0.01), no TRT × DAY interactions were found for these proteins.
diScuSSioN
A primary function of the mammalian liver is to coordinate whole-body energy and N metabolism. Hepatic transport and intermediary metabolism of glutamate are critical to these processes as glutamate is a central substrate for hepatic ureagenesis, gluconeogenesis, glutathione production, de novo protein synthesis, and nitrogen shuttling via glutamine (Meijer et al., 1990; Watford, 2000) . An important aspect of glutamate metabolism in the liver is the heterogeneity of Gln/Glu metabolism. Specifically, Gln, arriving from the peripheral tissues via the portal vein, is efficiently absorbed by periportal hepatocytes and deaminated by glutaminase (liver-type) to release ammonia and Glu. Alanine transaminase (glutamic-pyruvic transaminase), also primarily expressed by periportal vs. pericentral hepatocytes, supports ammonia production by transaminating Ala to pyruvate (Welsh, 1972) , producing Glu from α-KG. Glutamate, in turn, can be deaminated by glutamate dehydrogenase to produce ammonia and α-KG. Ammonia from peripheral Gln and Ala now can be incorporated into carbamoyl phosphate for ureagenesis, whereas the remaining Glu is available for conversion to α-KG (as an anapleurotic reaction to replenish the citric acid cycle), used for gluconeogenesis, used for protein synthesis, or transported into the sinusoids.
When released into the sinusoidal blood, Glu is available for absorption by "down-acinus" pericentral hepatocytes, which express the high-affinity system X − AG activity (Haussinger and Gerok, 1983) . If absorbed by pericentral hepatocytes, Glu and the "scavenged" sinusoidal ammonia that escapes incorporation into urea by periportal hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus completing the hepatic Gln-Glu cycle (Moorman et al., 1989 (Moorman et al., , 1990 Wagenaar et al., 1994) . Besides supporting Gln synthesis by GS, pericentral hepatocyte-localized system X − AG uptake of Glu complements pericentral hepatocyte-specific synthesis of glutathione synthesis by glutamylcysteine ligase and glutathione synthetase (Braeuning et al., 2006) , as well as supplying Glu as source of gluconeogenic carbons and for de novo protein synthesis (Watford, 2000) .
High-affinity glutamate transporters are members of the solute carrier family 1A (SLc1A) and function to mediate the Na + -dependent, concentrative uptake of glutamate, aspartate, and cysteine across cell membranes. In bovine liver, EAAC1 (SLC1A1) and GLT-1 4 Means in a row that lack the common letter differ (P ≤ 0.06.) (SLC1A2) are the only known system X − AG transporters (Howell et al., 2001) . In rodents, it has been shown that endoplasmic reticulum-localized GTRAP3-18 (a.k.a. addicsin, ADP-ribosylation factor-like 6 interacting protein 5/ARL6IP5, PRAF3) binds and inhibits the function of EAAC1 and GLT-1 (Ruggiero et al., 2008; Watabe et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is proportional to GTRAP3-18 content (Lin et al., 2001) .
The findings of Exp. 1 and 2 demonstrate that the liver tissue of aged cows has a reduced expression of ALT and GS and increased amounts of GTRAP3-18, whether managed under pasture or corn silage feeding regimens. Thus, the hypotheses of Exp. 1 and 2 are accepted. As discussed above, ALT and GS expressions are critical for optimal N recycling in hepatocytes, and GTRAP3-18 content is inversely proportional to EAAC1 activity (Lin et al., 2001; Ruggiero et al., 2008) . Thus, the findings that ALT and GS content was decreased, and GTRAP3-18 was increased, indicating that the capacity for ammonia production, ammonia incorporation into Gln, and EAAC1-mediated high-affinity glutamate transport capacity by pericentral hepatocytes was impaired in aged vs. young cows. Therefore, the hepatic findings of Exp. 1 and 2 suggest that the capacity for plasma membrane glutamate uptake, intracellular glutamate production, and glutamine synthesis likely are reduced in liver tissue of aged vs. young cows.
Although the content of hepatic glutaminase was not assessed in this set of experiments, the tendency for lower free Gln concentration in homogenates of aged vs. young cows (Table 4) , but no change in Glu, is consistent with the above findings. That hepatic Ala and Orn concentrations did not differ between aged and young cows suggests that Ala and Orn were not metabolized to yield Glu by periportal-expressed ALT or pericentral-expressed ornithine amino acid transaminase, respectively (Wagenaar et al., 1994; Braeuning et al., 2006) . The former conclusion is consistent with the decreased ALT content. That hepatic free Orn and Arg concentrations did not differ between aged and young cows (Table 4) suggests that urea cycle capacity was not altered, despite decreased GS content. Combined, the level of free AA concentration and reduced ALT and GS contents in hepatic homogenates of aged vs. young cows suggest a decreased periportal hepatic capacity to produce Glu by transamination of Ala to pyruvate and α-keto acid to Glu that is complemented by a decreased need for Glu uptake capacity by pericentral hepatocytes as substrate for GS to produce Gln. This latter concept is consistent with the finding of increased aged cow content of GTRAP3-18, the inhibitor of pericentrally expressed EAAC1 and GLT-1 (Stoll et al., 1991; Ruggiero et al., 2008) .
Preliminary findings from our laboratory (Sipe, 2004) indicated that liver GS mRNA and protein content is upregulated in finishing steers by use of SYNOVEX-S ear implants. This finding was inconsistent with the finding that estrogen did not affect GS activity in cultured primary rat hepatocytes (Sirma et al., 1996) , but was consistent with the findings that GS activity and protein content in rat C6-glioma cells can be increased by estradiol administration (Haghighat, 2005) and that supplemental estradiol upregulates GS mRNA and protein content in the hypothalamus and hippocampus of humans (Blutstein et al., 2006) . With regard to the sensitivity of other Gln-Glu metabolism associated proteins, the activities of ALT and AST in the brain, heart, liver, kidney, and uterus of menopausal rats were downregulated by estradiol or the combination of estradiol and progesterone (Moorthy et al., 2005) .
Collectively, the findings of Exp. 3 demonstrate that administration of estradiol (COMPUDOSE ear implants) to aged beef cows increased (1) plasma estradiol and (2) hepatic expression of GS, but not that of other proteins that support hepatic glutamate metabolism. Thus, the hypotheses of Exp. 3 are accepted, except that estradiol administration did not decrease expression of AST and ALT. To understand the full physiological significance of these findings to aged beef cows, the characterization of putative biological mechanisms of estradiol-induced stimulation of hepatic GS expression, determination if extra-hepatic tissues also are sensitive to estradiol-induced upregulation of GS expression, and characterization of the effects of estradiol implants on tissue biochemical profiles are needed. Currently, COMPUDOSE is approved for use in suckling beef steer calves, beef steers growing on pasture, and beef steers and heifers fed in confinement for slaughter (FDA, 2015) . The results of this study suggest that COMPUDOSE implants also may benefit the finishing of aged beef cows for slaughter. Therefore, to understand the potential of these findings toward improving the value of slaughter cows, additional experimentation is needed to characterize the optimal timing of estradiol administration with feeding of diets capable of supporting BW gain and the effect of COMPUDOSE on the compositional gain of carcasses.
In summary, there are 3 salient observations from this study. To our knowledge, this is the first report of reduced liver GS and ALT protein content in aged cows. Second, the levels of plasma estradiol resulting from COMPU-DOSE implantation in aged cycling beef cows have been characterized and are, to our knowledge, the first report of actual plasma estradiol concentrations resulting from COMPUDOSE implantation of cows. Third, the hypothesis that hepatic GS protein expression can be upregulated by exogenous estradiol supplementation is accepted-as
